J B Chemicals and Pharmaceuticals Ltd
BSE:506943
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
J B Chemicals and Pharmaceuticals Ltd
BSE:506943
|
IN |
|
V
|
Victorian Plumbing Group PLC
LSE:VIC
|
UK |
|
Mission Group PLC
F:M7K
|
UK |
|
C
|
China Gold International Resources Corp Ltd
SWB:JI3
|
CA |
|
Norske Skog ASA
F:0BQ
|
NO |
|
H
|
Hemisphere Energy Corp
F:N4Q1
|
CA |
|
BGSF Inc
F:BGK0
|
US |
Wall St Price Targets
JBCHEPHARM Price Targets Summary
J B Chemicals and Pharmaceuticals Ltd
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is JBCHEPHARM's stock price target?
Not Available
JBCHEPHARM does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for J B Chemicals and Pharmaceuticals Ltd?
Projected CAGR
12%
Over the last 14 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 12%.
What is the Gross Profit forecast for J B Chemicals and Pharmaceuticals Ltd?
Projected CAGR
41%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 14%. The projected CAGR for the next 2 years is 41%.
What is the Operating Income forecast for J B Chemicals and Pharmaceuticals Ltd?
Projected CAGR
23%
Over the last 14 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 3 years is 23%.
What is the Pre-Tax Income forecast for J B Chemicals and Pharmaceuticals Ltd?
Projected CAGR
28%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 2 years is 28%.
What is the Net Income forecast for J B Chemicals and Pharmaceuticals Ltd?
Projected CAGR
22%
Over the last 14 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 3 years is 22%.